| 5EA Stock | | | EUR 11.95 0.19 1.62% |
President
Todd Young is Chief Financial Officer, Executive Vice President of Elanco Animal Health since 2018.
| Age | 51 |
| Tenure | 6 years |
| Phone | 877 352 6261 |
| Web | https://www.elanco.com |
Elanco Animal Management Efficiency
The company has return on total asset
(ROA) of
0.0189 % which means that it generated a profit of $0.0189 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(0.0104) %, meaning that it generated substantial loss on money invested by shareholders. Elanco Animal's management efficiency ratios could be used to measure how well Elanco Animal manages its routine affairs as well as how well it operates its assets and liabilities.
Elanco Animal Health has accumulated 6.03
B in total debt with debt to equity ratio
(D/E) of 0.77, which is about average as compared to similar companies. Elanco Animal Health has a current ratio of 1.61, which is within standard range for the sector. Debt can assist Elanco Animal until it has trouble settling it off, either with new capital or with free cash flow. So, Elanco Animal's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Elanco Animal Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Elanco to invest in growth at high rates of return. When we think about Elanco Animal's use of debt, we should always consider it together with cash and equity.
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana. ELANCO ANIMAL operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 10200 people. Elanco Animal Health (5EA) is traded on Frankfurt Exchange in Germany and employs 27 people.
Management Performance
Elanco Animal Health Leadership Team
Elected by the shareholders, the Elanco Animal's board of directors comprises two types of representatives: Elanco Animal inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elanco. The board's role is to monitor Elanco Animal's management team and ensure that shareholders' interests are well served. Elanco Animal's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elanco Animal's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joshua Smiley, Independent Director | |
| Chris Keeley, VP Officer | |
| Carl McMillian, Independent Director | |
| Sarena Lin, Executive Vice President, Global Marketing, Corporate Strategy and Transformation | |
| Jeffrey Simmons, President, Chief Executive Officer, Director | |
| Denise ScotsKnight, Independent Director | |
| David Kinard, Executive Vice President of Human Resources | |
| David Urbanek, Executive Vice President - Manufacturing, Quality | |
| Aaron Schacht, Executive Vice President - Innovation, Regulatory, Business Development | |
| R Hoover, Independent Chairman of the Board | |
| Larbi Lier, VP Asia | |
| Kirk McDonald, Independent Director | |
| James Meer, Chief Accounting Officer, Vice President | |
| Art Garcia, Independent Director | |
| Kapila Anand, Independent Director | |
| Michael Harrington, Independent Director | |
| Todd Young, Chief Financial Officer, Executive Vice President | |
| David Ricks, Independent Director | |
| Marcela Kirberger, Gen VP | |
| Shawn McKee, Sr Animal | |
| Deborah Kochevar, Independent Director | |
| Lawrence Kurzius, Independent Director | |
| Ramiro Cabral, Executive Vice President - Elanco International | |
| Aarti Shah, Independent Director | |
| John Bilbrey, Independent Director | |
| MichaelBryant Hicks, Executive Vice President General Counsel, Corporate Secretary | |
Elanco Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Elanco Animal a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Elanco Stock
When determining whether Elanco Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elanco Animal's
financial statements, including income statements, balance sheets, and cash flow statements, to assess its
financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elanco Animal Health Stock.
Outlined below are crucial reports that will aid in making a well-informed decision on Elanco Animal Health Stock: Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
You can also try the
Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Please note, there is a significant difference between Elanco Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elanco Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elanco Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.